We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AXIA6:BMFBOVESPAAXIA Energia SA Non-Cum Perp Pfd Registered Shs Analysis

Data as of 2026-06-12 - not real-time

R$55.78

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

AXIA Energia is trading at roughly half of its DCF‑derived fair value of BRL 117.8, implying a **38 % upside** potential. The stock sits just above the technical support level of BRL 55.19 and below resistance at BRL 61.81, with a neutral trend but an RSI of 30 suggesting oversold conditions. A bullish MACD histogram (positive) and an increasing volume trend reinforce the possibility of a short‑term rebound. Recent Q1 2026 results delivered a 14 % EPS beat and a 60 % YoY jump in EBITDA to BRL 8.6 bn, though revenue slipped 0.4 % and the share price fell 6.6 % post‑earnings. The company’s price‑to‑earnings multiple of ~12.7 is well below the industry average of 20.5, highlighting a **value tilt**. Meanwhile, the fear‑and‑greed index sits at “Extreme Greed,” indicating strong market appetite for risk‑on assets like AX Energia.
AX Energia offers an attractive dividend yield of over 10 % with a payout ratio near 91 %, which, despite a modest free‑cash‑flow shortfall, remains supported by robust operating cash flow. The balance sheet shows a high debt‑to‑equity of 64.7 % and total debt exceeding BRL 78 bn, introducing leverage concerns that must be monitored. As a Brazilian renewable‑utility, the firm is subject to medium regulatory risk and geographic risk tied to Brazil’s economic environment. Its beta of 0.7 and 30 % 30‑day volatility suggest moderate market sensitivity but higher price swings than typical utilities. Given the blend of strong earnings momentum, substantial upside, and a solid dividend, the stock is **undervalued** and suitable for investors seeking both growth and income. We therefore recommend buying on the current dip, holding for the medium term, and remaining cautious over the long horizon due to debt and regulatory exposure.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Oversold RSI indicating potential bounce
  • Bullish MACD histogram and rising volume
  • Support level near current price with strong dividend yield

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF upside of ~38%
  • Q1 earnings beat and EBITDA surge
  • Attractive dividend yield relative to sector

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High dividend payout but elevated debt-to-equity
  • Medium regulatory and geographic risks
  • Renewable asset base provides stable cash flows

Key Metrics & Analysis

Financial Health

Revenue Growth22.10%
Profit Margin21.89%
P/E Ratio12.7
ROE7.86%
ROA1.97%
Debt/Equity64.67
P/B Ratio1.3
Op. Cash FlowR$14.1B
Free Cash FlowR$-425324864
Industry P/E20.5

Technical Analysis

TrendNeutral
RSI30.5
SupportR$55.19
ResistanceR$61.81
MA 20R$57.97
MA 50R$63.69
MA 200R$54.79
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair ValueR$117.84
Target PriceR$76.99
Upside/Downside38.02%
GradeUndervalued
TypeBlend
Dividend Yield10.46%

Risk Assessment

Beta0.70
Volatility31.46%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.